The world's first immuno-therapeutic leprosy vaccine Leprovac would be launched commercially by Cadila Pharmaceuticals by June. The company received approval on January 16 from the Drugs Controller of India to manufacture trial batches of the vaccine developed by Dr. Pran Talwar's group at the National Institute of Immunology in New Delhi.